Eight drugs expected to reach blockbuster status by 2021, says report


The 2017 “Drugs to Watch” report predicts that eight new drugs will enter the market this year and each achieve $1 billion in annual sales by 2021.

Drugs to watch, report, blockbuster, Clarivate Analytics, Regeneron, Sanofi, AstraZeneca, Novo Nordisk, Lilly, Incyte, Merck, Novartis, Tesaro, drugs, FDA